Exploring the epigenetic susceptibility mechanisms of lung cancer through DNA methylation markers

Cancer. 2024 Mar 15;130(6):848-850. doi: 10.1002/cncr.35203. Epub 2024 Jan 18.

Authors

Christian Rolfo¹, Marzia Del Re^{1

2}, Alessandro Russo³

Affiliations

¹ Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
² Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
³ Department of Onco-Hematology, Papardo Hospital, Messina, Italy.

PMID: 38236782
DOI: 10.1002/cncr.35203

No abstract available

Publication types

Editorial
Comment

MeSH terms

Biomarkers, Tumor / genetics
DNA Methylation
Epigenesis, Genetic
Humans
Lung Neoplasms* / genetics

Substances

Biomarkers, Tumor